Hypertension and Cerebral Vasoreactivity
Published Version
https://doi.org/10.1161/hypertensionaha.110.160002Metadata
Show full item recordCitation
Hajjar, Ihab, Peng Zhao, David Alsop, Vera Novak. "Hypertension and Cerebral Vasoreactivity." Hypertension 56, no. 5 (2010): 859-864. DOI: 10.1161/hypertensionaha.110.160002Abstract
Hypertension is associated with microvascular and macrovascular brain injury but its direct influence on the cerebral circulation is not fully clear. Our objective was to investigate the association of hypertension with global and regional cerebral vasoreactvity to CO2 using continuous arterial spin labeling magnetic resonance imaging, independent of stroke and white matter hyperintensities. Participants (n=62; mean age 66.7±1.0 years, 55% women, 84% white, 65% hypertension, 47% stroke) underwent arterial spin labeling perfusion MRI during normal breathing, 5% CO2 rebreathing, and hyperventilation as well as 24-hour ambulatory blood pressure monitoring. Vasoreactivity was the slope of the regression between cerebral perfusion and end-tidal CO2. White matter hyperintensity volumes were quantified. Nighttime dipping was calculated as the percent decline in nighttime/daytime blood pressure. After accounting for stroke and white matter hyperintensity volume, hypertensive participants had lower global vasoreactivity (1.11±0.13 vs. 0.43±0.1 ml/100gm/min/mmHg, p= 0.0012). Regionally, this was significant in the frontal, temporal and parietal lobes. Higher mean systolic blood pressure was associated with lower vasoreactivity (decreased by 0.11 units/10 mm Hg increase in systolic blood pressure, p=0.04), but nighttime dipping was not (p=0.2). The magnitude of decrease in vasoreactivity in hypertension without stroke was comparable to the magnitude of decrease in vasoreactivity in stroke without hypertension. Hypertension has a direct negative effect on the cerebrovascular circulation independent of white matter hyperintensities and stroke that is comparable to that seen with stroke. Since lower vasoreactivity is associated with poor outcomes, studies of the impact of antihypertensive on vasoreactivity are important.Other Sources
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3040032/Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAACitable link to this page
https://nrs.harvard.edu/URN-3:HUL.INSTREPOS:37369355
Collections
- HMS Scholarly Articles [17714]
Contact administrator regarding this item (to report mistakes or request changes)